相关实验视频

Updated: Jan 11, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

免疫检查点抑制剂在肝脏内胆管癌中的研究进展

Ziwen Yin¹, Lin Zhang¹, Jiexu Li¹

¹Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Shandong Second Medical University, Weifang, China.

Annals of medicine

|November 14, 2025

概括

免疫检查点抑制剂 (ICI) 在肝脏内胆管癌 (ICC) 治疗中表现有前途. 组合疗法,包括化疗和向药物,对于克服耐药性和改善ICC患者的治疗结果至关重要.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胆道癌症胆道癌症胆道癌症

背景情况:

肝脏内胆管癌 (ICC) 是一种罕见但具有攻击性的胆道癌.
免疫疗法,特别是免疫检查点抑制剂 (ICI),为ICC提供不断发展的治疗策略.
尽管取得了进展,但在优化ICI对ICC的有效性方面仍然存在挑战.

研究的目的:

对ICC的免疫疗法进行全面审查,重点关注免疫检查点抑制剂.
分析瘤微环境在免疫逃脱和ICI有效性中的作用.
探索目前的挑战,局限性和未来的方向在ICC免疫疗法.

主要方法:

对瘤微环境的分析,以了解免疫检查点和瘤免疫逃生.
对ICC的ICI进行临床前和临床试验的系统审查.
在ICC免疫治疗中研究组合疗法策略和向疗法.

主要成果:

与ICI一起的单疗法在ICC中取得了有限的成功.
组合疗法 (ICI与化疗) 显示出协同效应并克服药物耐药性.
向疗法,包括氨酸激酶和IDH抑制剂,在ICC中表现出抗瘤活性.

结论:

在ICC管理中,ICI发挥着至关重要的作用.
组合疗法策略对于解决耐药性和提高疗效至关重要.
综合治疗方法和持续的研究对于推进ICC治疗至关重要.

关键词:

在肝脏内发生的胆管癌,胆管癌.免疫检查点抑制剂免疫检查点抑制剂免疫疗法免疫疗法瘤微环境是一个微环境.

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.